Decision-making considerations for Chemotherapy:
|
|
|
|
|
|
|
|
Physical |
0.7 (0.8) |
0-2 |
0-2 |
0.7(0.8) |
0.7(0.8) |
0.8(0.8) |
0.06 |
Negative balance |
1.6 (1.4) |
0-5 |
0-5 |
1.2(1.3) |
1.5(1.4) |
2.0(1.3) |
<0.0001 |
Positive balance |
2.4 (1.0) |
0-3 |
0-3 |
2.7(0.7) |
2.4(1.0) |
2.0(1.1) |
<0.0001 |
Concrete considerations |
1.1 (1.2) |
0-4 |
0-4 |
1.2(1.2) |
1.0(1.2) |
1.1(1.2) |
0.39 |
Family and friends |
0.4 (0.5) |
0-1 |
0-1 |
0.4(0.5) |
0.4(0.5) |
0.3(0.5) |
0.12 |
Decision-making considerations for Hormonal Therapy:
|
|
|
|
|
|
|
|
Physical |
0.6 (0.5) |
0-1 |
0-1 |
0.6(0.5) |
0.6(0.5) |
0.6(0.5) |
1.0 |
Negative balance |
1.1 (1.3) |
0-5 |
0-5 |
1.0(1.3) |
1.1(1.3) |
1.3(1.4) |
0.01 |
Positive balance |
2.7 (0.7) |
0-3 |
0-3 |
2.8(0.5) |
2.7(0.7) |
2.5(0.8) |
<0.0001 |
Concrete Considerations |
0.8 (1.0) |
0-3 |
0-3 |
0.8(1.1) |
0.7(1.0) |
0.8(1.0) |
0.58 |
Family and friends |
0.3 (0.5) |
0-1 |
0-1 |
0.3(0.5) |
0.3(0.5) |
0.3(0.5) |
0.99 |
Psychosocial Factors
|
|
|
|
|
|
|
|
Attitude towards Chemotherapy
|
2.9 (0.6) |
1-4 |
1-4 |
3.0(0.5) |
2.9(0.6) |
2.7(0.6) |
<0.0001 |
You are less likely to have the cancer come back if you have chemotherapy |
3.0 (1.0) |
1-4 |
1-4 |
3.2(1.0) |
3.0(1.0) |
2.7(1.1) |
<0.0001 |
Chemotherapy does not help you live longer |
1.9 (1.1) |
1-4 |
1-4 |
1.7(1.0) |
1.9(1.0) |
2.0(1.1) |
0.001 |
Chemotherapy could cause long-term health problem |
2.8 (1.0) |
1-4 |
1-4 |
2.7(1.0) |
2.8(0.9) |
2.8(1.0) |
0.06 |
Chemotherapy is not as effective in older women as it is in younger women |
1.7 (1.0) |
1-4 |
1-4 |
1.7(0.9) |
1.7(1.0) |
1.9(1.0) |
0.01 |
Chemotherapy kills all remaining cancer cells |
2.7 (1.1) |
1-4 |
1-4 |
2.9(1.0) |
2.7(1.1) |
2.5(1.0) |
0.0002 |
Chemotherapy is experimental |
1.9 (1.0) |
1-4 |
1-4 |
1.8(1.0) |
1.9(1.0) |
2.0(1.1) |
0.35 |
The side effects of chemotherapy are worse than the disease |
2.2 (1.2) |
1-4 |
1-4 |
2.1(1.2) |
2.1(1.1) |
2.4(1.1) |
0.0007 |
Attitude towards Hormonal Therapy
|
2.9 (0.6) |
1-4 |
1-4 |
2.9(0.6) |
3.0(0.5) |
2.9(0.6) |
0.054 |
You are less likely to have the cancer come back if you have Hormonal Therapy |
3.1 (0.9) |
1-4 |
1-4 |
3.1(0.9) |
3.2(0.9) |
3.1(1.0) |
0.09 |
Hormonal Therapy does not help you live longer |
1.9 (1.0) |
1-4 |
1-4 |
1.8(1.0) |
1.7(1.0) |
2.1(1.1) |
<0.0001 |
Hormonal Therapy could cause long-term health problem |
2.4 (0.9) |
1-4 |
1-4 |
2.5(0.9) |
2.5(0.9) |
2.3(1.0) |
0.02 |
Hormonal Therapy is not as effective in older women as it is in younger women |
1.7 (0.9) |
1-4 |
1-4 |
1.9(1.0) |
1.5(0.8) |
1.8(1.0) |
<0.0001 |
Hormonal Therapy kills all remaining cancer cells |
1.9 (1.0) |
1-4 |
1-4 |
1.8(1.0) |
1.9(1.1) |
2.0(1.0) |
0.47 |
Hormonal Therapy is experimental |
2.1 (1.0) |
1-4 |
1-4 |
2.0(1.0) |
2.1(1.0) |
2.1(1.0) |
0.45 |
The side effects of Hormonal Therapy are worse than the disease |
1.6 (0.9) |
1-4 |
1-4 |
1.6(0.9) |
1.5(0.9) |
1.6(0.9) |
0.41 |
Treatment Expectations for Chemotherapy
|
|
|
|
|
|
|
|
Fatigue |
6.7 (2.2) |
0-10 |
0-10 |
6.4(2.2) |
6.8(2.2) |
6.6(2.2) |
0.02 |
Nausea |
5.7 (2.8) |
0-10 |
0-10 |
5.5(2.8) |
5.8(2.8) |
8.8(2.9) |
0.35 |
Hearing loss |
1.3 (2.2) |
0-10 |
0-10 |
1.1(1.9) |
1.1(2.1) |
1.7(2.4) |
0.001 |
Pain |
4.3 (2.8) |
0-10 |
0-10 |
4.1(2.6) |
4.3(2.8) |
4.4(2.9) |
0.45 |
Side effects |
6.4 (2.5) |
0-10 |
0-10 |
6.5(2.5) |
6.5(2.5) |
6.3(2.6) |
0.71 |
Fatalism
|
19.6 (3.2) |
8-32 |
9-31 |
18.9(3.4) |
19.6(3.2) |
20.3(3.0) |
<0.0001 |
Social Support
|
4.3 (0.7) |
1-5 |
1.4-5 |
4.3(0.7) |
4.3(0.7) |
4.2(0.6) |
0.76 |
Emotional/Information Support |
34.1 (4.9) |
8-40 |
8-40 |
34.4(4.7) |
34.3(4.9) |
33.5(4.9) |
0.03 |
Tangible Support |
17.2 (3.2) |
4-20 |
4-20 |
17.2 (3.2) |
17.3(3.3) |
17.1(3.1) |
0.70 |
Affectionate Support |
13.7 (2.2) |
3-15 |
3-15 |
13.7(2.2) |
13.7(2.2) |
13.6(2.1) |
0.84 |
Positive Social Interaction |
12.9 (2.3) |
3-15 |
3-15 |
12.8(2.4) |
12.9(2.3) |
12.9(2.1) |
0.86 |
Structural Social Support
|
14.0 (13.9) |
Write-in |
0 – 200 |
13.7(11.1) |
14.9(15.9) |
13.0(10.0) |
0.11 |
Provider-related Factors and Communication
|
|
|
|
|
Patient Involvement in Treatment Decision
|
12.5 (2.5) |
3-18 |
4-18 |
12.4(2.4) |
12.6(2.6) |
12.4(2.4) |
0.28 |
The doctor gave me the responsibility for deciding how to deal with my breast cancer |
4.3 (1.1) |
1-6 |
1-6 |
4.2(1.1) |
4.3(1.2) |
4.3(1.0) |
0.56 |
The doctor asked me to choose a treatment for my breast cancer |
3.6 (1.2) |
1-6 |
1-6 |
3.5(1.2) |
3.7(1.3) |
3.7(1.1) |
0.19 |
The doctor gave me all the information needed about my breast cancer |
4.6 (1.0) |
1-6 |
1-6 |
4.6(1.0) |
4.7(1.0) |
4.5(1.0) |
0.08 |
Provider Communication for Chemotherapy
|
18.0 (3.6) |
4-24 |
4 - 24 |
18.1(3.5) |
18.3(3.5) |
17.3(3.6) |
0.0004 |
The doctor gave you enough information to make your own decision about chemotherapy treatment |
4.8 (1.0) |
1-6 |
1-6 |
4.8(1.0) |
4.8(1.0) |
4.6(1.0) |
0.08 |
The doctor fully explained the benefits of chemotherapy. |
4.6 (1.1) |
1-6 |
1-6 |
4.7(1.0) |
4.7(1.0) |
4.4(1.1) |
<0.0001 |
The doctor fully explained the risks of chemotherapy |
4.4 (1.1) |
1-6 |
1-6 |
4.5(1.1) |
4.5(1.1) |
4.2(1.2) |
0.0006 |
The doctor did not ask your opinion about taking chemotherapy. |
2.8 (1.2) |
1-6 |
1-6 |
2.8(1.2) |
2.7(1.2) |
2.8(1.2) |
0.15 |
Provider Communication for Hormonal Therapy
|
15.5 (2.7) |
4-24 |
4-24 |
15.3(2.9) |
15.8(2.5) |
15.3(2.7) |
0.04 |
The doctor gave you enough information to make your own decision about Hormonal Therapy |
4.4 (1.1) |
1-6 |
1-6 |
4.3(1.2) |
4.4(1.1) |
4.3(1.1) |
0.36 |
The doctor fully explained the benefits of Hormonal Therapy |
4.4 (1.0) |
1-6 |
1-6 |
4.3(1.0) |
4.5(1.0) |
4.3(1.0) |
0.02 |
The doctor fully explained the risks of Hormonal Therapy |
4.0 (1.1) |
1-6 |
1-6 |
3.9(1.1) |
4.1(1.1) |
3.9(1.1) |
0.05 |
The doctor did not ask your opinion about taking Hormonal Therapy |
2.9 (1.2) |
1-6 |
1-6 |
2.9(1.2) |
2.8(1.3) |
2.9(1.1) |
0.77 |
Medical Mistrust
|
20.6 (7.1) |
13-65 |
3-49 |
21.0(7.2) |
20.6(7.3) |
20.3(6.6) |
0.45 |
Suspicion |
9.2 (3.6) |
6-30 |
2-24 |
9.3(3.5) |
9.2(3.7) |
9.2(3.5) |
0.94 |
Discrimination |
6.1 (2.7) |
3-15 |
2-15 |
6.3(2.7) |
6.2(2.9) |
5.9(2.4) |
0.21 |
Lack of support |
5.3 (2.1) |
3-15 |
2-15 |
5.5(2.1) |
5.3(2.1) |
5.2(1.9) |
0.26 |